FGF2 promotes the proliferation of injured granulosa cells in premature ovarian failure via Hippo-YAP signaling pathway
Authors:
Open Access
- 24 April 2024
- journal article
- research article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 589, 112248
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Cisplatin in cancer treatmentBiochemical Pharmacology, 2022
- Bone Marrow-Derived Mesenchymal Stem Cells Reverse Radiotherapy-Induced Premature Ovarian Failure: Emphasis on Signal Integration of TGF-β, Wnt/β-Catenin and Hippo PathwaysStem Cell Reviews and Reports, 2021
- Interaction between growing oocytes and granulosa cells in vitroReproductive Medicine and Biology, 2019
- Human placenta‐derived mesenchymal stem cells inhibit apoptosis of granulosa cells induced by IRE1α pathway in autoimmune POF miceCell Biology International, 2019
- Lung endothelial cell-targeted peptide-guided bFGF promotes the regeneration after radiation induced lung injuryBiomaterials, 2018
- Hippo pathway functions as a downstream effector of AKT signaling to regulate the activation of primordial follicles in miceJournal of Cellular Physiology, 2018
- Current approaches for the treatment of premature ovarian failure with stem cell therapyBiomedicine & Pharmacotherapy, 2018
- Fertility preservation for female cancer patientsInternational Journal of Clinical Oncology, 2018
- Fibroblast growth factor 2 (FGF2) and vascular endothelial growth factor A (VEGFA) synergistically promote steroidogenesis and survival of cultured buffalo granulosa cellsAnimal Reproduction Science, 2017
- Fibroblast growth factor-2 regulation of sprouty and NR4A genes in bovine ovarian granulosa cellsJournal of Cellular Physiology, 2010